Allspring Global Investments’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
VCM
VPM
Allspring Global Investments's EW Position: Q1 2026 in Review
Allspring Global Investments increased its Edwards Lifesciences (EW) stake by 221% in Q1 2026, buying an estimated $117M and bringing the position to 2,060,891 shares worth $167M. The position accounts for 0.28% of the portfolio, ranked #86.
Allspring Global Investments first reported a position in EW in Q4 2021 and has held it in 18 quarters since. The position peaked at $344M in Q4 2021. 1,287 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Allspring Global Investments held 2,060,891 shares of Edwards Lifesciences worth $167M as of Q1 2026.
- Allspring Global Investments bought 1,419,022 Edwards Lifesciences shares in Q1 2026, an estimated $117M.
- Edwards Lifesciences made up 0.28% of Allspring Global Investments's portfolio in Q1 2026, its #86 holding.
- Allspring Global Investments first reported a position in Edwards Lifesciences in Q4 2021 and has held it in 18 quarters since.
- Allspring Global Investments's Edwards Lifesciences position peaked at $344M in Q4 2021.
- 1,287 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.